Amylyx Pharmaceuticals (AMLX) Assets (2021 - 2026)
Amylyx Pharmaceuticals' Assets came in at $264.56 million for Q2 2026, up 36.0% from $194.6 million a year earlier but down 9.9% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Amylyx Pharmaceuticals' Assets was $332.65 million, up 71.8% from FY2024.
- Assets carries a four-year compound annual growth rate of 33.2% (FY2021 to FY2025).
- Going back by year, Assets was $193.63 million in FY2024 (-62.6%), $517.45 million in FY2023 (+32.2%), $391.45 million in FY2022 (+270.6%) and $105.61 million in FY2021.
- The five-year range for quarterly Assets is $105.61 million (Q4 2021) to $517.45 million (Q4 2023).
- Year-over-year, Assets has increased for four consecutive quarters, with an average decline of 1.4% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q4 2022 (growth of 270.6%), and the weakest in Q4 2024 (a decline of 62.6%).
- Business Quant data shows AMLX's Assets at $293.6 million (Q1 2026), $332.65 million (Q4 2025) and $362.74 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Amylyx Pharmaceuticals | 3.32 Bn | 3.32 Bn | - | 264.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 264.56 Mn |
| Mar 31, 2026 | 293.60 Mn |
| Dec 31, 2025 | 332.65 Mn |
| Sep 30, 2025 | 362.74 Mn |
| Jun 30, 2025 | 194.60 Mn |
| Mar 31, 2025 | 219.68 Mn |
| Dec 31, 2024 | 193.63 Mn |
| Sep 30, 2024 | 250.71 Mn |
| Jun 30, 2024 | 332.16 Mn |
| Mar 31, 2024 | 417.46 Mn |
| Dec 31, 2023 | 517.45 Mn |
| Sep 30, 2023 | 466.58 Mn |
| Jun 30, 2023 | 453.59 Mn |
| Mar 31, 2023 | 407.96 Mn |
| Dec 31, 2022 | 391.45 Mn |
| Sep 30, 2022 | 181.44 Mn |
| Jun 30, 2022 | 225.24 Mn |
| Mar 31, 2022 | 274.44 Mn |
| Dec 31, 2021 | 105.61 Mn |
API Access
Amylyx Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();